HomeNewsBusinessMarketsMorgan Stanley warns of global recession in 2020, says RBI could slash rates by 40-65 bps in Q2

Morgan Stanley warns of global recession in 2020, says RBI could slash rates by 40-65 bps in Q2

The global investment bank expects combined monetary and fiscal easing to help revive the global economy from 3QCY20, but a contraction in YoY growth in 1HCY20 still looks inevitable.

March 17, 2020 / 20:12 IST
Story continues below Advertisement

Factoring the worst, Morgan Stanley in a note on March 17, warned investors that the seismic waves of COVID-19 are likely to trigger a global recession.

"Global recession in 2020 is now our base case scenario," Morgan Stanley Chief Economist Chetan Ahya said in a note on March 17. “We expect 2020 global growth to dip to 0.9 percent, the lowest since the global financial crisis when global growth bottomed at -0.5 percent in 2009. This time will be worse than the global recession of 2001,” the note added.

Story continues below Advertisement

Under the base case scenario for India, Morgan Stanley estimates India’s growth rate at around 4.5 percent till Q4CY20, and in bear case, it could be near 4 percent.

The Reserve Bank of India (RBI), the global investment bank expects, could slash policy rates by a cumulative 40-65 basis points in the second quarter of the calendar.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show